What dose of Lyrica (pregabalin) is equivalent to gabapentin 400 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pregabalin Dose Equivalent to Gabapentin 400mg

The equivalent dose of pregabalin (Lyrica) to gabapentin 400mg is approximately 65-70mg, based on a 1:6 conversion ratio.

Conversion Ratio

The most reliable evidence for dose conversion comes from clinical research demonstrating that pregabalin is approximately 6 times more potent than gabapentin 1. This means:

  • Gabapentin 400mg ≈ Pregabalin 65-70mg
  • Gabapentin 1200mg ≈ Pregabalin 200mg
  • Gabapentin 1800mg ≈ Pregabalin 300mg
  • Gabapentin 3600mg ≈ Pregabalin 600mg

Evidence Supporting This Conversion

A direct substitution study in postherpetic neuralgia patients replaced gabapentin with pregabalin at one-sixth the gabapentin dosage while maintaining the same dosing frequency 1. Patients experienced no significant changes in pain scores, with many reporting faster onset and longer duration of action with pregabalin. This 6:1 ratio has been validated in clinical practice.

Additional research confirms pregabalin's superior potency, showing that pregabalin 300mg/day provides comparable analgesia to gabapentin 1200mg/day in postoperative pain management 2. The two doses demonstrated equivalent analgesic effects, opioid-sparing properties, and patient satisfaction.

Pharmacokinetic Advantages of Pregabalin

Pregabalin offers distinct advantages over gabapentin 3:

  • Linear absorption: Bioavailability remains ≥90% regardless of dose (vs. gabapentin's 60% dropping to 33% at higher doses)
  • Predictable pharmacokinetics: First-order absorption with proportional dose-response
  • Faster onset: Peak concentrations within 1 hour (vs. 3-4 hours for gabapentin)
  • More straightforward dosing: No saturable absorption issues

Practical Conversion Approach

When converting from gabapentin 400mg:

  1. Calculate pregabalin dose: Divide gabapentin dose by 6 (400mg ÷ 6 = 67mg)
  2. Round to practical dosing: Use pregabalin 75mg as the nearest available strength
  3. Match dosing frequency: If gabapentin was given TID, use pregabalin 25mg TID; if BID, use pregabalin 37.5mg BID (though 50mg BID is more practical)

Transition Methods

Two validated approaches exist for switching 4:

  • Immediate transition: Stop gabapentin and start pregabalin at the next scheduled dose
  • Gradual transition: Use 50% of each drug for 4 days, then switch completely to pregabalin

Both methods maintain therapeutic drug levels without significant gaps in coverage.

Important Caveats

Renal adjustment required: Both medications require dose reduction in renal impairment 5. Calculate creatinine clearance and adjust accordingly.

Peripheral edema risk: Pregabalin shows higher incidence of peripheral edema compared to gabapentin 1, though this was observed in small studies and requires monitoring.

Cardiovascular considerations: Recent evidence suggests pregabalin may carry increased heart failure risk compared to gabapentin, particularly in patients with pre-existing cardiovascular disease (AHR 1.85) 6. Exercise caution in this population.

Titration after conversion: While the 1:6 ratio provides equivalent baseline dosing, some patients may require further titration. When increasing pregabalin doses, do so gradually as side effects (somnolence, dizziness) can worsen 1.

Substance abuse history: Use pregabalin cautiously in patients with substance abuse history, as it carries Schedule V classification in the US 7, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.